Related Experiment Video

Updated: Aug 6, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Parental views on the introduction of an infant pneumococcal vaccine

Tracey Chantler1, Sarah Newton, Amanda Lees

  • 1Oxford Vaccine Group, Center for Clinical Vaccinology and Tropical Medicine, Department of Paediatrics, University of Oxford, Churchill Hospital, Oxford.

Community Practitioner : the Journal of the Community Practitioners' & Health Visitors' Association
|August 2, 2006
PubMed

Insights

Parents desire clear information on the safety and effectiveness of the heptavalent pneumococcal conjugate vaccine (PnC7) due to limited knowledge of pneumococcal disease. Restoring trust in immunisation is crucial for vaccine acceptance.

Area of Science:

  • Pediatrics
  • Public Health
  • Vaccinology

Background:

  • Streptococcus pneumoniae causes significant early childhood illness and death.
  • The heptavalent pneumococcal conjugate vaccine (PnC7) can prevent most infant invasive pneumococcal infections.
  • PnC7 is being introduced into the UK childhood immunisation program.

Purpose of the Study:

  • To explore parental understanding of pneumococcal disease.
  • To assess parental views on the introduction of PnC7.
  • To identify information needs for effective vaccine communication.

Main Methods:

  • Qualitative study involving 23 interviews and 2 focus groups.
  • Participants were parents of children under two years of age.
  • Thematic analysis of interview and focus group data.

Main Results:

  • Parental confidence in immunisation is impacted by the MMR controversy.
  • Parents have limited knowledge of pneumococcal disease.
  • Key themes include confidence, anxiety, trust, and response to new immunisations.
  • Parents seek information on PnC7 safety and effectiveness.

Conclusions:

  • Effective communication is needed to address parental concerns about PnC7.
  • Information delivery must rebuild trust in vaccination programs.
  • Understanding parental perspectives is vital for successful vaccine uptake.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...